Cardiovascular disease: risk assessment and reduction, including lipid modification

Recommendation ID: CG181/1
Question: What is the effectiveness of age alone and other routinely available risk factors compared with the formal structured multifactorial risk assessment to identify people at high risk of developing CVD?
Any explanatory notes (if applicable): Why this is important: Current risk assessment tools rely on a complex set of data derived from demographic, lifestyle, physiological and biochemical parameters. The principal determinant of CVD risk is age, and this may be sufficient to identify high-risk populations. However, focusing on age alone may result in people being missed who are at higher risk as a result of other factors that do not require access to intensive resources, such as smoking status, family history and deprivation. It is important therefore to assess age against validated simplified and complex CVD risk tools when predicting people at high risk.

Source guidance details

Comes from guidance: Cardiovascular disease: risk assessment and reduction, including lipid modification
Number: CG181
Date issued: July 2014

Is this a recommendation for the use of a technology only in the context of research?	No
Is it a recommendation that suggests collection of data or the establishment of a register?	No
Last Reviewed	07/10/2014